These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
171 related articles for article (PubMed ID: 8724551)
21. [Value of beta-blocker therapy in treatment of coronary heart disease and sudden cardiac death with special reference to carvedilol]. Zehender M; Just H Z Kardiol; 1996; 85 Suppl 7():23-9. PubMed ID: 9082680 [TBL] [Abstract][Full Text] [Related]
22. Prevention of sudden death in patients with coronary artery disease. Bloom JM N Engl J Med; 2000 Apr; 342(17):1291-2. PubMed ID: 10787334 [No Abstract] [Full Text] [Related]
23. The role of beta-blockers in preventing sudden death in heart failure. Teerlink JR; Massie BM J Card Fail; 2000 Jun; 6(2 Suppl 1):25-33. PubMed ID: 10908095 [TBL] [Abstract][Full Text] [Related]
27. The role of the implantable cardioverter-defibrillator for prevention of sudden cardiac death. Josephson ME; Callans DJ; Buxton AE Ann Intern Med; 2000 Dec; 133(11):901-10. PubMed ID: 11103061 [TBL] [Abstract][Full Text] [Related]
32. Sudden death due to cardiac arrhythmias. Huikuri HV; Castellanos A; Myerburg RJ N Engl J Med; 2001 Nov; 345(20):1473-82. PubMed ID: 11794197 [No Abstract] [Full Text] [Related]
33. [Heart failure]. Yonezawa M; Komuro I Nihon Rinsho; 2002 Jul; 60(7):1422-6. PubMed ID: 12136624 [TBL] [Abstract][Full Text] [Related]
34. [The current status of the prevention and treatment of sudden death]. Pedrote A; Errazquin F Rev Esp Cardiol; 1995 Nov; 48(11):710-21. PubMed ID: 8532940 [TBL] [Abstract][Full Text] [Related]
35. Potential of non-antiarrhythmic drugs to provide an innovative upstream approach to the pharmacological prevention of sudden cardiac death. Boriani G; Valzania C; Diemberger I; Biffi M; Martignani C; Bertini M; Ziacchi M; Domenichini G; Saporito D; Rapezzi C; Branzi A Expert Opin Investig Drugs; 2007 May; 16(5):605-23. PubMed ID: 17461735 [TBL] [Abstract][Full Text] [Related]
36. [Circadian and weekly distribution of malignant ventricular arrhythmias in patients with coronary heart disease or dilatative cardiomyopathy who have an implanted cardioverter-defibrillator]. Wolpert C; Jung W; Spehl S; Schumacher B; Omran H; Schimpf R; Lüderitz B Dtsch Med Wochenschr; 1998 Feb; 123(6):140-5. PubMed ID: 9505952 [TBL] [Abstract][Full Text] [Related]
37. Treatment with beta-blockers for the primary prevention of the cardiovascular complications of hypertension. Staessen JA; Wang JG; Birkenhäger WH; Fagard R Eur Heart J; 1999 Jan; 20(1):11-24. PubMed ID: 10075137 [No Abstract] [Full Text] [Related]
38. Sudden cardiac death and the potential role of beta-adrenoceptor-blocking drugs. Rajman I; Kendall MJ Postgrad Med J; 1993 Dec; 69(818):903-11. PubMed ID: 7907178 [TBL] [Abstract][Full Text] [Related]
39. Sudden cardiac death and implantable cardioverter-defibrillators. Turakhia MP Am Fam Physician; 2010 Dec; 82(11):1357-66. PubMed ID: 21121520 [TBL] [Abstract][Full Text] [Related]
40. Rationale, design, and baseline characteristics of the DANish randomized, controlled, multicenter study to assess the efficacy of Implantable cardioverter defibrillators in patients with non-ischemic Systolic Heart failure on mortality (DANISH). Thune JJ; Pehrson S; Nielsen JC; Haarbo J; Videbæk L; Korup E; Jensen G; Hildebrandt P; Steffensen FH; Bruun NE; Eiskjær H; Brandes A; Thøgersen AM; Egstrup K; Hastrup-Svendsen J; Høfsten DE; Torp-Pedersen C; Køber L Am Heart J; 2016 Sep; 179():136-41. PubMed ID: 27595688 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]